National Health Investors (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The firm presently has a $75.00 target price on the real estate investment trust’s stock. Zacks Investment Research‘s price objective would suggest a potential upside of 14.45% from the company’s current price.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
Several other equities analysts also recently commented on the stock. Berenberg Bank lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Wednesday, December 2nd. ValuEngine cut National Health Investors from a “hold” rating to a “sell” rating in a report on Thursday, October 1st. KeyCorp raised National Health Investors from an “underweight” rating to a “sector weight” rating in a research note on Monday, December 14th. Finally, BMO Capital Markets cut shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 price target on the stock. in a report on Thursday, January 7th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $65.63.
They called the 2020 crash 45 days early. Nobody expects what they’re predicting now…
Shares of NHI stock opened at $65.53 on Tuesday. The company has a market capitalization of $2.93 billion, a P/E ratio of 15.38 and a beta of 0.85. National Health Investors has a fifty-two week low of $31.37 and a fifty-two week high of $91.12. The company has a debt-to-equity ratio of 1.02, a quick ratio of 13.13 and a current ratio of 13.13. The stock has a 50 day moving average price of $67.70 and a two-hundred day moving average price of $62.85.
National Health Investors (NYSE:NHI) last issued its earnings results on Monday, November 9th. The real estate investment trust reported $0.95 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.48). The firm had revenue of $84.30 million during the quarter, compared to analysts’ expectations of $82.87 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.42 earnings per share. As a group, equities analysts predict that National Health Investors will post 5.63 earnings per share for the current year.
In other National Health Investors news, Director Robert G. Adams bought 1,000 shares of the firm’s stock in a transaction on Tuesday, November 17th. The stock was acquired at an average price of $66.45 per share, with a total value of $66,450.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert G. Adams purchased 2,000 shares of the company’s stock in a transaction dated Monday, December 14th. The stock was bought at an average cost of $67.75 per share, for a total transaction of $135,500.00. The disclosure for this purchase can be found here. 5.74% of the stock is owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the stock. Marshall Wace North America L.P. purchased a new stake in shares of National Health Investors during the first quarter valued at approximately $31,000. Private Advisor Group LLC bought a new position in National Health Investors in the 2nd quarter valued at approximately $31,000. Van ECK Associates Corp boosted its stake in National Health Investors by 23.5% during the 3rd quarter. Van ECK Associates Corp now owns 1,298 shares of the real estate investment trust’s stock valued at $78,000 after purchasing an additional 247 shares during the last quarter. Avantax Advisory Services Inc. bought a new stake in shares of National Health Investors in the 3rd quarter worth $202,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in shares of National Health Investors in the third quarter worth $209,000. 62.41% of the stock is owned by institutional investors.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Article: Why is the LIBOR significant?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
An insider trade occurs when a corporate executive (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company’s stock. Company insiders are required by law to regularly report their stock purchases and sales to the SEC.
Tracking a company’s insider trades is a metric that can be used to identify the direction that the company’s executives believes that the company is headed. If a number of insiders purchase more shares of their company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
For example, if Microsoft’s CEO, CFO and COO all recently purchased additional shares of Microsoft stock, that would be an indication that there could be unreported news that may positively effect Microsoft’s stock price in the near future.
This slideshow lists the 15 companies that have had the highest levels of insider buying within the last 180 days.